Your browser doesn't support javascript.
loading
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-ß.
Hart, Kevin M; Fabre, Thomas; Sciurba, Joshua C; Gieseck, Richard L; Borthwick, Lee A; Vannella, Kevin M; Acciani, Thomas H; de Queiroz Prado, Rafael; Thompson, Robert W; White, Sandra; Soucy, Genevieve; Bilodeau, Marc; Ramalingam, Thirumalai R; Arron, Joseph R; Shoukry, Naglaa H; Wynn, Thomas A.
Afiliação
  • Hart KM; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Fabre T; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
  • Sciurba JC; Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, Québec, Canada.
  • Gieseck RL; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Borthwick LA; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Vannella KM; Tissue Fibrosis and Repair Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Acciani TH; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • de Queiroz Prado R; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Thompson RW; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • White S; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Soucy G; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Bilodeau M; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
  • Ramalingam TR; Département de pathologie et biologie cellulaire, Université de Montréal, Montréal, Québec, Canada.
  • Arron JR; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
  • Shoukry NH; Département de médecine, Université de Montréal, Montréal, Québec, Canada.
  • Wynn TA; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Sci Transl Med ; 9(396)2017 06 28.
Article em En | MEDLINE | ID: mdl-28659437
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Transformador beta / Progressão da Doença / Hepatopatia Gordurosa não Alcoólica / Imunidade / Doenças Metabólicas Limite: Animals / Humans / Male Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Transformador beta / Progressão da Doença / Hepatopatia Gordurosa não Alcoólica / Imunidade / Doenças Metabólicas Limite: Animals / Humans / Male Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos